News from mylan inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 29, 2015, 07:00 ET

Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo

 Mylan N.V. (NASDAQ: MYL) today announced that it received regulatory clearance from the European Commission under the European Union Merger...

Jul 27, 2015, 15:58 ET

Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders

 Mylan N.V. (NASDAQ: MYL) today announced that it will hold its extraordinary general meeting of shareholders in connection with its proposed...

Jul 27, 2015, 06:42 ET

Mylan Comments on Teva's Agreement to Acquire Allergan's Generic Drug Unit

 Mylan N.V. (NASDAQ: MYL) today issued the following statement regarding Teva's (NYSE and TASE: TEVA) announcement of its entry into an...

Jul 24, 2015, 15:28 ET

Mylan Schedules Second Quarter 2015 Financial Results Conference Call and Live Webcast

Mylan N.V. (Nasdaq: MYL), a leading global pharmaceutical company, announced today that it will host a conference call and live webcast on...

Jul 23, 2015, 08:47 ET

Mylan Acknowledges Exercise of Full Call Option by the Independent Foundation

 Mylan N.V. (NASDAQ: MYL) today acknowledged the exercise of the full call option by Stichting Preferred Shares Mylan, an independent...

Jul 14, 2015, 07:30 ET

Mylan One of First to Launch Generic Version of Namenda® Tablets

Mylan N.V. (Nasdaq: MYL) today announced the U.S. launch of Memantine Hydrochloride Tablets USP, 5 mg and 10 mg, which is the generic version of...

Jul 09, 2015, 07:30 ET

Mylan Launches First Generic Targretin® Capsules

 Mylan N.V. (Nasdaq: MYL) today announced the U.S. launch of Bexarotene 75mg Capsules, which is the generic version of Valeant's...

Jun 18, 2015, 11:55 ET

U.S. Court of Appeals for the Federal Circuit Finds Teva's '808 Copaxone® Patent Invalid

Mylan N.V. (Nasdaq: MYL) today commented on the ruling by the U.S. Court of Appeals for the Federal Circuit, which again has found Teva's U.S....

Jun 16, 2015, 09:19 ET

Mylan Issues Statement in Response to Abbott's Support for Perrigo Transaction

Mylan N.V. (NASDAQ: MYL) today issued the following statement regarding Abbott Laboratories' (NYSE: ABT) announced intention to support Mylan's...

Jun 16, 2015, 07:30 ET

Pulmatrix and Mylan Enter Into ex-U.S. Development Agreement for PUR0200

Pulmatrix (Nasdaq: PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies for serious pulmonary diseases, today...

Jun 08, 2015, 03:00 ET

Mylan Launches First Bioequivalent Alternative to Combination Asthma Therapy Seretide® Evohaler® (Salmeterol Xinafoate/Fluticasone Propionate) Under the Brand Name Sirdupla™ in the UK

 Mylan N.V. (Nasdaq: MYL) today announced that it has launched the first bioequivalent alternative to GlaxoSmithKline's Seretide®...

Jun 03, 2015, 11:00 ET

Mylan to Present at Goldman Sachs 36th Annual Global Healthcare Conference

Mylan N.V. (Nasdaq: MYL), a leading global pharmaceutical company, today announced that the Company will present at Goldman Sachs 36th Annual...

Jun 02, 2015, 15:50 ET

Mylan Launches Generic Version of Seasonique® Tablets

 Mylan N.V. (Nasdaq: MYL) today announced the U.S. launch of Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.15 mg/0.03 mg and Ethinyl...

Jun 02, 2015, 15:30 ET

Mylan Launches Generic INTUNIV® Tablets

 Mylan N.V. (Nasdaq: MYL) today announced the U.S. launch of Guanfacine Extended-release Tablets, 1 mg, 2 mg, 3 mg, and 4 mg, which is the...

May 26, 2015, 16:48 ET

Mylan to Present at the Bernstein Strategic Decisions Conference

 Mylan N.V. (Nasdaq: MYL), a leading global pharmaceutical company, today announced that Mylan CEO Heather Bresch, will be presenting at the...

May 25, 2015, 09:47 ET

Mylan/Perrigo Clarification

 Mylan N.V. (NASDAQ: MYL) today announced that it was asked by the Irish Takeover Panel to issue the following clarification and retraction in...

May 12, 2015, 16:00 ET

Mylan to Present at the UBS Global Healthcare Conference

 Mylan N.V. (Nasdaq: MYL) today announced that the Company will present at the UBS Global Healthcare Conference on Monday May 18, 2015. The...

May 12, 2015, 07:30 ET

Mylan to Present at the Bank of America Merrill Lynch Health Care Conference

 Mylan N.V. (Nasdaq: MYL) today announced that the Company will present at the Bank of America Merrill Lynch Health Care Conference on...

May 07, 2015, 06:30 ET

Un ícono de la moda, una chef y un actor se unen para compartir historias personales sobre el manejo de alergias potencialmente mortales en nueva campaña

Mylan N.V. (Nasdaq: MYL), una importante compañía farmacéutica global, anunció hoy el lanzamiento de EpiPen® On...

May 07, 2015, 06:30 ET
Myland

Fashion Icon, Chef and Actor Join Together to Share Personal Stories of Managing Life-Threatening Allergies in New Campaign

 Mylan N.V. (Nasdaq: MYL), a leading global pharmaceutical company, today announced the launch of EpiPen® On Location™. This...